Hyperfine, Inc. (HYPR)
About Hyperfine, Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $13.6M
- Net income
- -$35.6M
- Total assets
- $55.3M
- Market cap
- $137.0M
- Gross margin
- 49.8%
- Operating margin
- -273.4%
- Net margin
- -262.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $13.6M
- Cost of revenue
- $6.8M
- Gross profit
- $6.8M
- Operating expenses
- $43.8M
- Operating income
- -$37.1M
- Income tax
- $0
- Net income
- -$35.6M
- EPS (basic)
- $-0.43
- EPS (diluted)
- $-0.43
Balance sheet
- Total assets
- $55.3M
- Current assets
- $50.9M
- Total liabilities
- $14.3M
- Current liabilities
- $11.7M
- Shareholders’ equity
- $41.0M
Cash flow
- Operating cash flow
- -$27.9M
- Investing cash flow
- -$1.2M
- Financing cash flow
- $27.5M
- Net cash flow
- -$1.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $137.0M
- EPS (diluted)
- $-0.43
- Shares outstanding
- 144.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 23, 2021
Hyperfine, Inc. (HYPR) Stock Price
- Reported a net loss of $35.6M in FY2025.
- Revenue grew 807% from FY2021 to FY2025.
- Gross margin of 49.8%, net margin -262.3%.
- Trading 57% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Hyperfine, Inc..
Write a review
News about Hyperfine, Inc.
News & sentiment via Polygon.io
Hyperfine, Inc.: frequently asked questions
Is Hyperfine, Inc. an American company?
Hyperfine, Inc. is a US-based company headquartered in Guilford, Connecticut, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Hyperfine, Inc. headquartered?
Hyperfine, Inc. is headquartered in Guilford, Connecticut, United States.
Is Hyperfine, Inc. publicly traded?
Yes — Hyperfine, Inc. is a publicly traded company. Its stock trades under the ticker symbol HYPR on the NASDAQ.
What does Hyperfine, Inc. do?
Hyperfine, Inc. is an American Medical Devices company in the Health & Beauty sector.
